Dudediligence.

Bio-Techne Corporation

TECHNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$289.5MSep ’24$297.0MDec ’24$316.2MMar ’25$317.0MJun ’25$286.6MSep ’25$295.9MDec ’25$311.4MMar ’26$321.2MJun ’26
Net income, by quarter
$33.6MSep ’24$34.9MDec ’24$22.6MMar ’25−$17.7MJun ’25$38.2MSep ’25$38.0MDec ’25$51.0MMar ’26$54.6MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenue$1.11B$1.14B$1.16B$1.22B$1.22B
Gross profit$756.5M$769.8M$769.7M$790.3M$799.1M
Operating income$296.6M$298.9M$206.7M$102.3M$251.9M
Net income$263.1M$285.4M$168.1M$73.4M$181.9M
Operating cash flow$325.3M$254.4M$299.0M$287.6M$292.1M
Free cash flow$280.4M$216.1M$236.1M$256.6M$263.2M
Cash$172.6M$180.6M$151.8M$162.2M$264.7M
Debt$255.9M$350.0M$319.0M$346.0M$200.0M
Shares outstanding156.6M157.6M158.2M155.0M156.1M